SAN DIEGO, Dec. 12, 2019 /PRNewswire/ -- Shareholder
Rights Law Firm Johnson Fistel, LLP, is investigating potential
claims against Abiomed, Inc. ("Abiomed ") (NASDAQ: ABMD)
on behalf of investors. Abiomed engages in the research,
development, and sale of medical devices to assist or replace the
pumping function of the failing heart.
Specifically, the investigation seeks to determine whether
certain statements regarding the Company's Impella heart
pumps were false and misleading when made. On
November 17, 2019, clinical studies
were presented at the American Heart Association's ("AHA") annual
meeting in Philadelphia that
presented data questioning the safety and effectiveness of
Abiomed's Impella heart pumps. Following this news, the price
of Abiomed shares plummeted $45.14
per share to close at $178.09 per
share on Monday, November 18, 2019, a
decline of more than 20%.
If you lost money, realized or unrealized on your Abiomed
investment, and are interested in learning more about
the investigation or your legal rights and remedies, please contact
Jim Baker
(jimb@johnsonfistel.com) by email or phone at 619-814-4471.
If emailing, please include a phone number.
Additionally, you can [click here to join this
action]. There is no cost or obligation to you.
About Johnson Fistel,
LLP:
Johnson Fistel, LLP is a nationally
recognized shareholder rights law firm with offices in California, New
York, and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
http://www.johnsonfistel.com. Attorney advertising. Past results do
not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
[click here to join this action]
View original
content:http://www.prnewswire.com/news-releases/abiomed-abmd-alert-johnson-fistel-launches-investigation-into-abiomed-inc-investors-encouraged-to-contact-firm-300973979.html
SOURCE Johnson Fistel, LLP